REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Qcs Pharma, S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Lessors of Other Real Estate Property | Research and Development in the Social Sciences and Humanities | Marketing Research and Public Opinion Polling
Full name: Qcs Pharma, S.R.O. Profile Updated: July 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Qcs Pharma, S.R.O. is based in Slovakia. The head office is in Vycapy - Opatovce. It operates in the Pharmacies and Drug Stores industry. It was established on May 31, 2005. Qcs Pharma, S.R.O. currently employs 5 - 9 (2025) people. There was a net sales revenue increase of 18.17% reported in Qcs Pharma, S.R.O.’s latest financial highlights for 2024. Its’ total assets recorded a growth of 37.63%. The net profit margin of Qcs Pharma, S.R.O. decreased by 0.89% in 2024.

Headquarters
Hlavna, 493/78
Vycapy - Opatovce; Postal Code: 95144

Contact Details: Purchase the Qcs Pharma, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Qcs Pharma, S.R.O. report to view the information.
Registered Capital:
Purchase the Qcs Pharma, S.R.O. report to view the information.
Financial Auditors:
Purchase the Qcs Pharma, S.R.O. report to view the information.
Incorporation Date:
May 31, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Qcs Pharma, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
18.17%▲
Total operating revenue
18.17%▲
Operating profit (EBIT)
-27.18%▼
EBITDA
-14.47%▼
Net Profit (Loss) for the Period
-59.35%▼
Total assets
37.63%▲
Total equity
21.37%▲
Operating Profit Margin (ROS)
-0.58%▼
Net Profit Margin
-0.89%▼
Return on Equity (ROE)
-57.42%▼
Debt to Equity Ratio
152%▲
Quick Ratio
0.16%▲
Cash Ratio
0.03%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo